As padel grows in popularity, the wellness event "Strong Body, Strong Game" explores how core-focused therapies and aesthetic ...

The global gastrointestinal devices market is projected to grow at a CAGR of ~7% during the forecast period. This expansion ...

The clinical data management systems market is expected to grow at a robust CAGR of 12% from 2025 to 2030. This growth is ...

The chronic lymphocytic leukemia therapeutics market is expected to grow at a compound annual growth rate of 7% from 2025 to ...

Overview of the MarketThe global Medical Robots Market is valued at USD 31.11 billion in 2024 and is projected to reach a ...

The AI-based clinical trials solution provider is expected to grow at a robust CAGR of approximately 20-25% over the forecast ...

Market OutlineThe Global Weight Loss Drugs Market is valued at USD 2.88 Billion in 2024 and is projected to reach a value ...

Overview of the MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to ...

Mipletamig's 85% frontline AML remission rate and favorable safety profile drive APVO's differentiated CD3 portfolio expansion with APVO455, a Nectin-4 x CD3 bispecific for multiple solid tumor ...

Trump said his administration will focus on research to unlock the medical uses of marijuana, and other priorities the marijuana industry has sought. However, will employees within the DEA continue ...

According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to Venofer® for the treatment of iron deficiency anemia in patients with ...

Global Insulin-Sensitizing Agents Market to Reach USD 22.1 Billion by 2025, Growing at 5% CAGR Through 2032 The global Insulin-Sensitizing Agents Market is poised for steady expansion, projected to ...